Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Discovery Platform
Sponsor : Perceptive Advisors
Deal Size : $300.0 million
Deal Type : Series A Financing
Kardigan Launches with Cozy $300M, Late-Stage Portfolio
Details : The funds from the financing will be used to advance Kardigan’s efforts in addressing the most critical unmet needs in cardiovascular diseases.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Discovery Platform
Sponsor : Perceptive Advisors
Deal Size : $300.0 million
Deal Type : Series A Financing